Loading...

COVID‑19 Alert: Stay home if you feel unwell. If you have a fever, cough and difficulty breathing, seek medical attention. Follow the directions of your local health authority. Source WHO

We have a lockdown, "Working from HOME" Please reach out for any queries at: help@alliedmarketresearch.com & Int'l : +1-503-894-6022, (UK) : +44-845-528-1300

New

Neurostimulation Devices Market by Device Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others) Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

A05193
Pages: 176
May 2020 | 1669 Views
 
Author(s) : Onkar Sumant & Snehal Manjrekar
Tables: 96
Charts: 32
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Neurostimulation Devices Market

Request Now !

Neurostimulation Devices Market Overview:

The global neurostimulation devices market size was valued at $4,387.50 million in 2018 and is projected to reach $11,257.38 million by 2026, registering a CAGR of 12.5% from 2019 to 2026. Neurological disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and cerebrovascular diseases affect the central nervous system (CNS) and peripheral nervous system (PNS) of the human body. To manage these neurological disorders, neurostimulation technique plays a vital role. The electrodes in the devices generate mild electrical impulses to supplement the neurological activities in the patients. These devices are can be implanted or can be external. Neurostimulation devices are directly placed within the brain, PNS or CNS. Spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, and vagus nerve stimulators are some of the neurostimulation devices used in treating patients with various diseases such as pain management, hearing loss, urinary incontinence, Parkinson's disease, and epilepsy.

Approximately 48 million people are affected in America and nearly 360 million people globally, according to the data published by the Hearing Health Foundation in 2020. Furthermore, as per the data published by the Epilepsy Centre, presently, around 50 million patients are living with epilepsy worldwide and around 2.4 million new cases are diagnosed annually. Moreover, majority of the epileptic cases are idiopathic, with no identifiable cause. In addition, according to the U.S. Centers for Disease Control and Prevention’s National Center for Health Statistics, in 2014, around 50% of older Americans experienced urinary or bowel leakage; around 25% had moderate to severe urinary leakage, and around 8% had moderate to severe bowel leakage. As per the data published by WHO, in 2017, the prevalence of urinary incontinence ranges from 9.9% to 36.1% (reported in population-based studies). These increase in incidences and rise in prevalence of neurological disorders are expected to fuel the growth of the market. 

Neurostimulation-Devices-Market-2019-2026

Get more information on this report : Request Sample Pages

The factors such as rise in prevalence of lifestyle diseases such as depression and chronic pain, increase in number of neurological disorders, and investment for neurological R&D drive the growth of the global neurostimulation devices market. Moreover, rise in demand for minimal invasive surgery, adoption of technologically advanced products, and surge in aging population also propel the growth of the market as they are more susceptible to neurological disorders, such as Epilepsy, Parkinson’s disease, Alzheimer’s disease, and chronic pain. However, side effects such as allergic reaction and tingling or prickling of the skin due to implantation of neurostimulation device into the body and increase in cost of devices are expected to restrain the growth of the market. Furthermore, availability of other treatment options such as drug therapies and surgeries restrict the market growth. On the contrary, research regarding the use of neurostimulators for managing diseases such as obsessive-compulsive disorders, interstitial cystitis, and asthma are ongoing and are expected to create lucrative opportunities for the growth of the neurostimulation devices market in the coming years.  

Global Neurostimulation Devices Market Segmentation

The neurostimulation devices market is classified on the basis of device type, application, and region. Based on device type, the neurostimulation devices market is divided into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. On the basis of application, the market is classified into pain management, hearing loss, urinary incontinence, Parkinson's disease, epilepsy, and others. Region wise, it is studied across North America, Europe, Asia-Pacific, and LAMEA.

Device type segment review

Based on device type, the neurostimulation devices market is divided into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. The spinal cord stimulators segment is the most lucrative segment in the global neurostimulation market. This is attributed to increase in usage of spinal cord stimulators for treating neuropathic pain and spinal injuries. In addition, upsurge in minimally invasive procedures and increase in healthcare spending further drive the market growth for spinal cord stimulators across the globe. The spinal cord stimulator segment is expected to grow at a significant CAGR, owing to usage of DBS in various diseases such as Parkinson's disease, obsessive-compulsive disorders, idiopathic dystonia, & essential tremor and growth in number of product approvals. 

Neurostimulation Devices Market
By Device Type

Your browser does not support the canvas element.

Spinal Cord Stimulators segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Application segment review

According to global neurostimulation devices market analysis, the application segment is classified into pain management, hearing loss, urinary incontinence, Parkinson's disease, epilepsy, and others. The pain management segment is the highest contributor to the neurostimulation devices market in 2018, due to increase in usage of neurostimulation devices for treating chronic and acute pain. The hearing loss segment is anticipated to grow at a considerable CAGR, owing to rise in incidences of hearing loss across the globe. Approximately 48 million people are affected in America and nearly 360 million people globally, according to the data published by Hearing Health Foundation in 2020.

Neurostimulation Devices Market
By Application

Your browser does not support the canvas element.

Pain Management segment holds a dominant position in 2018 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Region segment review

The North America market accounted for major in the global neurostimulation devices market share in 2018. Development of innovative neurostimulators, approvals by health authorities for novel techniques in neurostimulators, and mergers & acquisitions to acquire novel technologies & products are significant market trends in North America. Rise in prevalence of neurological disorders, increase in geriatric population, favorable reimbursement rates, and introduction of innovative technology are expected to drive of the market in this region. In addition, research and development activities to develop new technologies to manage pain and neurological disorders such as Parkinson’s disease, dystonia, and epilepsy are expected to increase the treatment options for patients and surgeons in the neurostimulation market. The market is expected to grow at a steady rate in future. The Asia-Pacific region offers lucrative opportunities to the players in the neurostimulator market, as it is anticipated to be the fastest growing market. Government and private initiatives to increase awareness regarding mental health and increase in incidence of neurological disorders drive the market growth. Factors such as improving healthcare infrastructure, rising number of healthcare reforms, and increasing healthcare expenditures in the emerging markets such as India and China to overcome the unmet medical needs in these regions boost the demand for neurostimulators. The report provides an extensive competitive analysis and profiles of the key neurostimulation devices market players such as Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, NeuroPace Inc., Nevro Corporation, Neuronetics Inc., NeuroSigma, Inc., and Synapse Biomedical Inc. 

Neurostimulation Devices Market
By Region

2026
North America 
Europe
Asia Pacific
Lamea

North America segment holds a dominant position in 2018 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current market trends and neurostimulation devices market forecast estimations from 2019 to 2026, which assists in identifying the prevailing neurostimulation devices market opportunities. 

  • An in-depth market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.

  • A comprehensive analysis of the factors that drive and restrain the neurostimulation devices market growth is provided.

  • Region-wise and country-wise market conditions are comprehensively analyzed in this report.

  • The projections in this report are made by analyzing the current neurostimulation devices market trends and future market potential from 2019 to 2026 in terms of value.

  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

  • The key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the market.

Key Market Segments

By Device Type

  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Others

By Application

  • Pain Management
  • Hearing Loss
  • Urinary Incontinence
  • Parkinson's Disease
  • Epilepsy
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Spain
    • Italy
    • UK
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Market dynamics

3.3.1.Drivers

3.3.1.1.Rise in prevalence of neurological disorders
3.3.1.2.Increase in investments in R&D for neurological disorders

3.3.2.Restraints

3.3.2.1.Adverse effects and risks associated with neurostimulation devices

3.3.3.Opportunities

3.3.3.1.Use of neurostimulators for new indications

CHAPTER 4:NEUROSTIMULATION DEVICES MARKET, BY DEVICE TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Spinal Cord Stimulators

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Deep Brain Stimulators

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Sacral Nerve Stimulators

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

4.5.Vagus Nerve Stimulators

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country

4.6.Others

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country

CHAPTER 5:NEUROSTIMULATION DEVICES MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Pain Management

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Hearing Loss

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Urinary Incontinence

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Parkinson's Disease

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country

5.6.Epilepsy

5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country

5.7.Others

5.7.1.Market size and forecast, by region
5.7.2.Market analysis, by country

CHAPTER 6:GLOBAL NEUROSTIMULATION DEVICES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by device type
6.2.3.Market size and forecast, by application
6.2.4.Market size and forecast, by country

6.2.4.1.U.S. market size and forecast, by device type
6.2.4.2.U.S. market size and forecast, by application
6.2.4.3.Canada market size and forecast, by device type
6.2.4.4.Canada market size and forecast, by application
6.2.4.5.Mexico market size and forecast, by device type
6.2.4.6.Mexico market size and forecast, by application

6.3.Europe

6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast, by device type
6.3.3.Market size and forecast, by application
6.3.4.Market size and forecast, by country

6.3.4.1.Germany market size and forecast, by device type
6.3.4.2.Germany market size and forecast, by application
6.3.4.3.France market size and forecast, by device type
6.3.4.4.France market size and forecast, by application
6.3.4.5.UK market size and forecast, by device type
6.3.4.6.UK market size and forecast, by application
6.3.4.7.Italy market size and forecast, by device type
6.3.4.8.Italy market size and forecast, by application
6.3.4.10.Rest of Europe market size and forecast, by device type
6.3.4.11.Rest of Europe market size and forecast, by application

6.4.Asia-Pacific

6.4.1.Key market trends and opportunities
6.4.2.Market size and forecast, by device type
6.4.3.Market size and forecast, by application
6.4.4.Market size and forecast, by country

6.4.4.1.Japan market size and forecast, by device type
6.4.4.2.Japan market size and forecast, by application
6.4.4.3.China market size and forecast, by device type
6.4.4.4.China market size and forecast, by application
6.4.4.5.India market size and forecast, by device type
6.4.4.6.India market size and forecast, by application
6.4.4.7.Australia market size and forecast, by device type
6.4.4.8.Australia market size and forecast, by application
6.4.4.9.Rest of Asia-Pacific market size and forecast, by device type
6.4.4.10.Rest of Asia-Pacific market size and forecast, by application

6.5.LAMEA

6.5.1.Key market trends and opportunities
6.5.2.Market size and forecast, by device type
6.5.3.Market size and forecast, by application
6.5.4.Market size and forecast, by country

6.5.4.1.Brazil market size and forecast, by device type
6.5.4.2.Brazil market size and forecast, by application
6.5.4.3.Saudi market size and forecast, by device type
6.5.4.4.Saudi market size and forecast, by application
6.5.4.5.South Africa market size and forecast, by device type
6.5.4.6.South Africa market size and forecast, by application
6.5.4.7.Rest of LAMEA market size and forecast, by device type
6.5.4.8.Rest of LAMEA market size and forecast, by application

CHAPTER 7:COMPANY PROFILES

7.1.Abbott Laboratories

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments

7.2.Aleva Neurotherapeutics SA

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Key strategic moves and developments

7.3.Boston Scientific Corporation

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments

7.4.ElectroCore Inc.

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance

7.5.EndoStim Inc.

7.5.1.Company overview
7.5.2.Operating business segments
7.5.3.Product portfolio

7.6.Medtronic plc

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
Source: Corporate Publications and AMR Analysis

7.7.NeuroPace Inc.

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Key strategic moves and developments

7.8.Nevro Corporation

7.8.1.Company overview
7.8.2.Operating business segment
7.8.3.Product portfolio
7.8.4.Business performances
7.8.5.Key strategic moves and developments

7.9.Neuronetics Inc.

7.9.1.Company overview
7.9.2.Neuronetics: Company Snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments

7.10.NeuroSigma Inc.

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Key strategic moves and developments

7.11.Synapse Biomedical Inc.

7.11.1.Company overview
7.11.2.Company snapshot
7.11.3.Operating business segments
7.11.4.Product portfolio
7.11.5.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL NEUROSTIMULATION DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 02.NEUROSTIMULATION DEVICES MARKET, FOR SPINAL CORD STIMULATORS BY REGION, 2018–2026 ($MILLION)
TABLE 03.NEUROSTIMULATION DEVICES MARKET, FOR DEEP BRAIN STIMULATORS BY REGION, 2018–2026 ($MILLION)
TABLE 04.NEUROSTIMULATION DEVICES MARKET, FOR SACRAL NERVE STIMULATORS BY REGION, 2018–2026 ($MILLION)
TABLE 05.NEUROSTIMULATION DEVICES MARKET, FOR VAGUS NERVE STIMULATORS BY REGION, 2018–2026 ($MILLION)
TABLE 06.NEUROSTIMULATION DEVICES MARKET, FOR OTHERS BY REGION, 2018–2026 ($MILLION)
TABLE 07.GLOBAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 08.NEUROSTIMULATION DEVICES MARKET, FOR PAIN MANAGEMENT, BY REGION, 2018–2026 ($MILLION)
TABLE 09.NEUROSTIMULATION DEVICES MARKET FOR HEARING LOSS, BY REGION, 2018–2026 ($MILLION)
TABLE 10.NEUROSTIMULATION DEVICES MARKET FOR URINARY INCONTINENCE, BY REGION, 2018–2026 ($MILLION)
TABLE 11.NEUROSTIMULATION DEVICES MARKET FOR PARKINSON'S DISEASE, BY REGION, 2018–2026 ($MILLION)
TABLE 12.NEUROSTIMULATION DEVICES MARKET FOR EPILEPSY, BY REGION, 2018–2026 ($MILLION)
TABLE 13.NEUROSTIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 14.GLOBAL NEUROSTIMULATION DEVICES MARKET BY REGION, 2018-2026, ($MILLION)
TABLE 15.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 16.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 17.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 18.U.S. NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 19.U.S. NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 20.CANADA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 21.CANADA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 22.MEXICO NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 23.MEXICO NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 24.EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 25.EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 26.EUROPE NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 27.GERMANY NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 28.GERMANY NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 29.FRANCE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 30.FRANCE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 31.UK NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 32.UK NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 33.ITALY NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 34.ITALY NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 35.REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 36.REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 37.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 38.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 39.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 40.JAPAN NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 41.JAPAN NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 42.CHINA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 43.CHINA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 44.INDIA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 45.INDIA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 46.AUSTRALIA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 47.AUSTRALIA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 48.REST OF ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 49.REST OF ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 50.LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 51.LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 52.LAMEA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 53.BRAZIL NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 54.BRAZIL NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 55.SAUDI NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 56.SAUDI NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 57.SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 58.SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 59.REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 60.REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 61.ABBOTT: COMPANY SNAPSHOT
TABLE 62.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 63.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 64.Aleva neurotherapeutics: company Snapshot
TABLE 65.ALEVA NEUROTHERAPEUTICS: OPERATING SEGMENT
TABLE 66.ALEVA NEUROTHERAPEUTICS: PRODUCT PORTFOLIO
TABLE 68.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 69.BOSTON: PRODUCT PORTFOLIO
TABLE 70.ELECTROCORE INC: COMPANY SNAPSHOT
TABLE 71.ELCTROCORE: OPERATING SEGMENTS
TABLE 72.ELECTROCORE INC: PRODUCT PORTFOLIO
TABLE 73.ENDOSTIM INC: OPERATING SEGMENT
TABLE 74.ENDOSTIM INC: PRODUCT PORTFOLIO
TABLE 75.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 76.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 77.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 78.NEUROPACE INC.: COMPANY SNAPSHOT
TABLE 79.NEUROPACE INC.: OPERATING SEGMENTS
TABLE 80.NEUROPACE INC.: PRODUCT PORTFOLIO
TABLE 81.NEVRO CORPORATION.: OPERATING SEGMENTS
TABLE 82.NEVRO CORPORATION.: PRODUCT PORTFOLIO
TABLE 83.NEURONETICS: OPERATING SEGMENT
TABLE 84.NEURONETICS : PRODUCT PORTFOLIO
TABLE 85.NEUROSIGMA INC: COMPANY SNAPSHOT
TABLE 86.NEUROSIGMA INC COMPANY: PRODUCT SEGMENT
TABLE 87.NEUROSIGMA INC: PRODUCT PORTFOLIO
TABLE 88.SYNAPSE BIOMEDICAL: COMPANY SNAPSHOT
TABLE 89.SYNAPSE BIOMEDICAL: OPERATING SEGMENT
TABLE 90.SYNAPSE BIOMEDICAL: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.NEUROSTIMULATION DEVICES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2016-2019*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2016-2019*
FIGURE 06.TOP IMPACTING FACTORS
FIGURE 07.NEUROSTIMULATION DEVICES, FOR SPINAL CORD STIMULATORS BY COUNTRY, 2018 & 2026 (%)
FIGURE 08.NEUROSTIMULATION DEVICES, FOR DEEP BRAIN STIMULATORS BY COUNTRY, 2018 & 2026 (%)
FIGURE 09.NEUROSTIMULATION DEVICES, FOR SACRAL NERVE STIMULATORS BY COUNTRY, 2018 & 2026 (%)
FIGURE 10.NEUROSTIMULATION DEVICES, FOR VAGUS NERVE STIMULATORS BY COUNTRY, 2018 & 2026 (%)
FIGURE 11.NEUROSTIMULATION DEVICES, FOR OTHERS BY COUNTRY, 2018 & 2026 (%)
FIGURE 12.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET, FOR PAIN MANAGEMENT BY COUNTRY, 2018 & 2026 (%)
FIGURE 13.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR HEARING LOSS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR URINARY INCONTINENCE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR EPILEPSY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18.ABBOTT LABORATORIES: NET SALES, 2016–2018 ($MILLION)
FIGURE 19.ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2018(%)
FIGURE 20.ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2018(%)
FIGURE 21.BOSTON: NET SALES, 2016–2018 ($MILLION)
FIGURE 22.BOSTON: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 23.BOSTON: REVENUE SHARE BY REGION, BY 2018%
FIGURE 24.ELECTROCORE.: NET SALES, 2016–2018 ($MILLION)
FIGURE 25.ELECTROCORE INC.: REVENUE SHARE BY REGION,2018 %
FIGURE 26.MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 27.MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 28.MEDTRONIC PLC: REVENUE SHARE BY REGION, 2018(%)
FIGURE 29.NEVRO CORPORATION.: NET SALES, 2016–2018 ($MILLION)
FIGURE 30.NEVRO CORPORATION.: REVENUE SHARE BY REGION,2018 %
FIGURE 31.NEURONETICS: NET SALES, 2016–2018 ($MILLION)
FIGURE 32.NEURONETICS: REVENUE SHARE BY REGION, 2018(%)

 
 

  The utilization of neurostimulation devices is expected to witness a significant rise with increase in diagnosis of neurological disorders. The neurostimulation devices market has piqued the interest of healthcare providers, owing to several benefits offered by these devices to treat neurological disorders and improve the quality of life of the patients. There have been remarkable technological advancements in these devices to provide advanced treatment options for the management of symptoms of neurological disorders. As the market is nascent and growing at a steady rate in developed nations, the Asia-Pacific and LAMEA regions are expected to offer high growth opportunities to the key players. 

Rise in incidence of neurological disorders, technological advancements, and increase in emphasis on management of symptoms of neurological disorders, such as Alzheimer's and Parkinson’s diseases are some of the factors that drive the market growth. However, lack of reimbursement and high cost of these devices hamper the market growth. Moreover, rise in geriatric population, which is susceptible to neurological disorders and increase in amount of stress in daily life add to the growth of the neurological disorders. In addition, emerging markets are gaining more importance for majority of the neurostimulation device manufacturers and distributors. Rapid growth was observed in the shipment of these devices to provide improved healthcare services in emerging nations, and this is expected to offset the challenging conditions in mature markets such as North America and Europe. 

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, Subscription @ $699 T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
 

A. The total market value of global neurostimulation devices market is $4,387.5 million in 2018.

A. The forecast period for global neurostimulation devices market is 2019 to 2026

A. The market value of global neurostimulation devices market in 2019 is $4,935.9 million

A. The base year is 2018 in global neurostimulation devices market

A. Top companies such as, Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, held a high market position in 2018.

A. Deep Brain Stimulators segment is the most influencing segment growing in the global neurostimulation devices market

A. The key trend in the global neurostimulation devices market is increase in prevalence of neurological disorders and surge in the neurological R&D investment by various major pharmaceutical giants drive the growth of the market.

A. Asia-Pacific is expected to grow at a highest CAGR of 14.6%, owing to increased awareness regarding mental health and rise in incidence of neurological disorders in China and India

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Neurostimulation Devices Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $0.00
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts